ABBV
NYSE · Biotechnology
Abbvie Inc
$246.04
+2.17 (+0.89%)
EPS Surprise History
Earnings Summary
Beats (Last 6)
5/6
Avg Surprise
+0.7%
Latest EPS
$3.65
YoY EPS Growth
+22.9%
History
6 quarters
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Q3 FY2026 | $3.67 | — | — | — | — |
| Jun 30, 2026 | Q2 FY2026 | $3.68 | $3.65 | -$0.03 | -0.7% | Miss |
| Apr 29, 2026 | Q2 FY2026 | $3.06 | — | — | — | — |
| Mar 31, 2026 | Q1 FY2026 | $2.65 | $2.65 | +$0.00 | +0.2% | Beat |
| Dec 31, 2025 | Q4 FY2025 | $2.71 | $2.71 | +$0.00 | +0.2% | Beat |
| Sep 30, 2025 | Q3 FY2025 | $1.81 | $1.86 | +$0.05 | +2.7% | Beat |
| Jun 30, 2025 | Q2 FY2025 | $2.94 | $2.97 | +$0.03 | +0.9% | Beat |
| Mar 31, 2025 | Q1 FY2025 | $2.43 | $2.46 | +$0.03 | +1.1% | Beat |